Orthofix Medical, Inc. (OFIX)
NASDAQHealth CareMedical - DevicesSnapshot 2026-09-04
$9.29-0.21%
Close 2026-09-04 · 1-day change
NASDAQHealth CareMedical - DevicesSnapshot 2026-09-04
QuarterlyIQ Insights · OFIX
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||||||
| Revenues | 833.2 | 822.3 | 799.5 | 746.6 | 460.7 | 464.5 | 406.6 | 460.0 | 453.0 | 433.8 | 409.8 | 396.5 | 402.3 | 397.6 | 440.2 | 435.5 |
| Total Revenues | — | — | — | — | — | — | — | — | — | 433.8 | 409.8 | 396.5 | 402.3 | 397.6 | 440.2 | 435.5 |
| Cost of Revenues | 239.1 | 256.3 | 253.6 | 260.4 | 123.5 | 114.9 | 101.9 | 100.6 | 96.6 | 93.0 | 87.9 | 86.5 | 98.9 | 106.9 | 100.7 | 96.4 |
| Gross Profit | 594.1 | 566.0 | 545.9 | 486.3 | 337.2 | 349.6 | 304.7 | 359.3 | 356.4 | 340.8 | 321.9 | 310.0 | 303.4 | 290.7 | 339.5 | 339.1 |
| Operating Expenses & Income | ||||||||||||||||
| Selling, General & Admin | 557.8 | 554.3 | 532.5 | 530.4 | 308.8 | — | — | — | — | — | — | — | — | — | — | — |
| R&D Expenses | 61.4 | 65.8 | 73.6 | 80.2 | 49.1 | 49.6 | 39.1 | 34.6 | 33.2 | 29.7 | 28.8 | 26.4 | 25.0 | 26.8 | 28.6 | 22.9 |
| Operating Income | (39.1) | (81.4) | (84.6) | (139.1) | (13.3) | (8.3) | (6.3) | (18.8) | 30.1 | 40.8 | 21.1 | 9.3 | 17.1 | (11.2) | 74.9 | 6.6 |
| Earnings from Continuing Operations | ||||||||||||||||
| Interest Expense | — | — | — | — | — | — | — | — | — | — | — | — | 1.8 | 1.8 | 4.2 | 5.4 |
| Interest & Investment Income | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 0.3 |
| Net Interest Expenses | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 5.1 |
| Other Non-Operating Income / Expenses | — | — | — | — | — | — | — | — | — | — | — | (0.7) | (4.7) | 0.6 | (5.8) | (8.0) |
| EBT, Incl. Unusual Items | (60.3) | (90.8) | (123.9) | (148.7) | (17.7) | (13.5) | (0.4) | (27.0) | 22.9 | 36.4 | 19.0 | 8.5 | 12.5 | (10.6) | 69.1 | (1.4) |
| Income Tax Expense | 1.4 | 1.4 | 2.1 | 2.7 | 2.0 | 24.9 | (2.9) | 1.4 | 9.1 | 29.1 | 15.5 | 10.8 | 16.2 | 7.6 | 23.9 | 14.4 |
| Net Income | ||||||||||||||||
| Net Income | (61.7) | (92.2) | (126.0) | (151.4) | (19.8) | (38.4) | 2.5 | (28.5) | 13.8 | 6.2 | 3.1 | (2.8) | (8.5) | (28.8) | 42.9 | (17.7) |
| Per Share | ||||||||||||||||
| Basic EPS | (1.51) | (2.33) | (3.30) | (4.12) | (0.98) | (1.95) | 0.13 | (1.51) | 0.73 | 0.34 | 0.17 | (0.15) | (0.46) | (1.54) | 2.26 | (0.97) |
| Diluted EPS | (1.51) | (2.33) | (3.30) | (4.12) | (0.98) | (1.95) | 0.13 | (1.51) | 0.72 | 0.34 | 0.17 | (0.15) | (0.46) | (1.54) | 2.21 | (0.97) |
| Revenue per Share | 20.37 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 40.9 | 39.6 | 38.1 | 36.7 | 20.1 | 19.7 | 19.3 | 18.9 | 18.5 | 18.1 | 18.1 | — | 18.5 | 18.7 | 19.0 | 18.2 |
| Diluted Weighted Avg Shares | 40.9 | 39.6 | 38.1 | 36.7 | 20.1 | 19.7 | 19.4 | 18.9 | 18.9 | 18.5 | 18.5 | — | 18.5 | 18.7 | 19.4 | 18.2 |
| Supplemental | ||||||||||||||||
| EBITDA | — | (4.1) | (24.6) | (86.0) | 15.8 | 21.3 | 24.3 | 5.9 | 48.8 | 60.9 | 41.9 | 30.2 | 40.0 | 11.6 | 93.2 | 29.8 |
| EBIT | (39.1) | (81.4) | (84.6) | (139.1) | (13.3) | (8.3) | (6.3) | (18.8) | 30.1 | 40.8 | 21.1 | 9.3 | 17.1 | (11.2) | 74.9 | 6.6 |
| Effective Tax Rate | -2.4% | — | — | -1.8% | -11.5% | -184.4% | 784.0% | -5.2% | 39.7% | 80.0% | 81.6% | 127.5% | 130.1% | -71.7% | 34.7% | -1059.6% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.